Investigating How the Brain Processes Different Experiences
Study Details
Study Description
Brief Summary
The goal of this clinical trial is to test the efficacy of an app-based program in reducing anxiety and exploring associated changes in brain activity.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The main question[s] it aims to answer are:
PRIMARY AIM: Confirm that the conscious experience of open/closed correlates with P/PCC activation/deactivation.
SECONDARY AIM: Determine if changes in P/PCC activity predict clinical outcomes (GAD-7 scores) in individuals with moderate to severe anxiety after using an app.
Participants may be asked to:
-
Complete a Zoom interview
-
Complete online surveys at baseline and 2 months post-treatment initiation
-
Complete MRIs at baseline and 2 months post-treatment initiation
-
Wear a smartwatch and answer daily questions about their anxiety
-
Use an app daily
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: App-Delivered Mindfulness Training (MT) The program is delivered via a smartphone-based platform, which includes a progression through 30+ daily modules of brief didactic and experience-based mindfulness training (videos and animations), app-triggered check-ins to encourage engagement, and user-initiated guided mindfulness exercises to help disrupt worry cycles in the moment. |
Behavioral: App-Delivered Mindfulness Training (MT)
The program is delivered via a smartphone-based platform, which includes a progression through 30+ daily modules of brief didactic and experience-based mindfulness training (videos and animations), app-triggered check-ins to encourage engagement, and user-initiated guided mindfulness exercises to help disrupt worry cycles in the moment.
|
Active Comparator: App-Delivered Coloring An app-based coloring book with a variety of designs to choose from including mandalas, animal patterns, and florals. It is designed to help individuals relax and reduce stress and anxiety based on the benefits found in past research studies. |
Behavioral: App-Delivered Coloring
An app-based coloring book with a variety of designs to choose from including mandalas, animal patterns, and florals. It is designed to help individuals relax and reduce stress and anxiety based on the benefits found in past research studies.
|
Outcome Measures
Primary Outcome Measures
- Change in GAD - 7 [collected at baseline and 2 month follow up apt]
Generalized Anxiety Disorder 7-items (GAD-7). The GAD-7 is a validated 7-item measure of anxiety rated on a 4-point Likert scale ranging from 0 (Not at all sure) to 3 (Nearly every day).
- Change From Baseline in Posterior Cingulate Cortex (PCC) Blood Oxygen Level Dependent (BOLD) Signal [collected at baseline and 2 month follow up apt]
BOLD signal change will be measured by fMRI and analyzed using statistical parametric mapping
Secondary Outcome Measures
- Penn State Worry Questionnaire (PSWQ) [collected at baseline and 2 month follow up apt]
The PSWQ is a validated 16-item self-report measure of worry with items presented on a 5-point Likert scale ranging from 1 (not at all typical of me) to 5 (very typical of me).
- Five Facet Mindfulness Questionnaire (FFMQ) non-reactivity scale [collected at baseline and 2 month follow up apt]
The non-reactivity scale is a validated subscale of the 39-item FFMQ which is a self-report psychological measure of mindfulness skills. This subscale contains 7 items which are presented on a 6-point Likert scale ranging from 1 (almost always) to 6 (almost never).
Other Outcome Measures
- Multidimensional Assessment of Interoceptive Awareness (MAIA) [collected at baseline and 2 month follow up apt]
The MAIA is a validated 32-item self-report questionnaire comprised of 8 subscales including: noticing, not-distracting, not-worrying, attention regulation, emotional awareness, self-regulation, body listening, and trusting. Items are rated on a 6-point Likert scale ranging from 0 (never) to 5 (always).
- Anxiety Sensitivity Index (ASI) [collected at baseline and 2 month follow up apt]
The ASI is a validated 16-item self-report measure of the fear of anxiety sensations. Items are rated on a 5-point Likert scale ranging from 0 (Very little) to 4 (Very much).
- Interest (I) Type and Deprivation (D) Type scale (I/D) [collected at baseline and 2 month follow up apt]
The I/D scale is a validated 10-item self-report measure of curiosity. Items are rated on a 4-point Likert scale ranging from 1 (Almost never) to 4 (Almost always).
- Acceptance & Action questionnaire (AAQ-II) [collected at baseline and 2 month follow up apt]
The AAQ-II is a validated 7-item self-report measure of experiential avoidance. Items are rated on a 7-point Likert scale ranging from 1 (Never true) to 7 (Always true).
- Intolerance of Uncertainty 12-item scale (IUS-12) [collected at baseline and 2 month follow up apt]
The IUS-12 is a validated 12-item self-report measure of intolerance of uncertainty. Items are rated on a 5-point Likert scale ranging from 1 (Not at all characteristic of me) to 5 (Entirely characteristic of me).
Eligibility Criteria
Criteria
Inclusion Criteria:
-
18 - 65 years
-
Able to travel to Brown University for research assessment
-
Able to speak English because all study activities will be conducted in English.
-
GAD-7 ≥ 10
-
Owns a smartphone
Exclusion Criteria:
-
If using psychotropic medication - not on a stable dosage at least 6 weeks
-
As needed (i.e., prn) benzodiazepine use
-
Psychotic disorder (e.g., bipolar disorder, schizophrenia, schizoaffective disorder, psychosis)
-
MRI contraindications
-
Claustrophobia
-
Recreational drug use past 2 weeks
-
Alcohol abuse
-
Pregnancy or plans to become pregnant
-
Cohabiting with a study participant
-
Weight ≥ 300 lbs (due to inability to fit in scanner)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Brown University | Providence | Rhode Island | United States | 02903 |
Sponsors and Collaborators
- Brown University
- Dartmouth College
- Tiny Blue Dot Foundation
Investigators
- Principal Investigator: Judson Brewer, MD, PhD, Brown University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2022003264